Why it was recalled
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
Product description
Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-406-01
Lot numbers, UPCs & expiration codes
Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484; Exp 8/2025 Lot# 19233490; Exp 8/2025
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0123-2024
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Nov 7, 2023
- FDA report date
- Dec 6, 2023
- Quantity
- 37,200 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
Original FDA data
Every field from FDA enforcement report D-0123-2024, exactly as published.
Show all FDA fields
- City
- Mahwah
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 93368
- Address
- 750 Corporate Dr
- Code information
- Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484; Exp 8/2025 Lot# 19233490; Exp 8/2025
- Postal code
- 07430-2009
- Report date
- Dec 6, 2023
- Product type
- Drugs
- Recall number
- D-0123-2024
- Classification
- Class II
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Product quantity
- 37,200 bottles
- Reason for recall
- Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-406-01
- Distribution pattern
- Nationwide
- Recall initiation date
- Nov 7, 2023
- Initial firm notification
- Letter
- Center classification date
- Nov 27, 2023